Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16% as of 11:55 a.m. EDT on Friday.
Here are the key takeaways from Insulet's third quarter:
Management expects the good times to continue into the fourth quarter. The company is projecting revenue to land between $123 million and $126 million, which represents 20% at the midpoint. This range compares favorably to Wall Street's estimate of $120.9 million.
Source: Fool.com
Insulet Corp. Aktie
179,35 €
1,49 %
Die Insulet Corp. Aktie wird von der Community stark bevorzugt: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Kursziel von 216 € für Insulet Corp. bedeutet eine deutliche Steigerung von über 20% gegenüber dem aktuellen Kurs von 179.35 €.
